Egyptian International Pharmaceuticals (EIPICO) (PHAR)

• Stock
• Company Profile
• News
• Announcements
• Fair Values
• Corporate Actions
• Earning Announcements
• News Reports
• Insider Trades
• Volume Statistics
• Financial Ratios
• IPOs
• Financial Statements
• Support and resistance
• More

News

3 March 09:31 AM EIPICO’s consolidated profits leap 33% in 2024

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) logged net profits after tax worth EGP 1.09 billion in 2024, up 33% year-on-year (YoY) from EGP 823 million. Total net sales jumped by 45% to EGP 7.59 billion at the end …

Financial Results

30 May 2024 02:50 PM EIPICO’s consolidated profit jumps to EGP 603m in Q1-24

Cairo – Mubasher: The consolidated net profit of Egyptian International Pharmaceutical Industries (EIPICO) soared to EGP 603.62 million in the first quarter (Q1) of 2024 from EGP 188.41 million in the same period a year earlier. Net sales surged …

Financial Results

8 April 2024 11:32 AM EIPICO unveils cash dividends

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) announced a cash dividend distribution of EGP 2 per share, according to a bourse disclosure. The dividends will be disbursed in two equal installments on 30 April and 29 …

Cash Dividends

29 February 2024 00:44 PM EIPICO’s consolidated profit hits EGP 823m in 2023

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) registered a consolidated profit for the year after tax of EGP 823.30 million in 2023 from EGP 643.76 million a year earlier. Net sales surged to EGP 5.23 billion last …

Financial Results

12 February 2024 11:30 AM EIPICO reports EGP 5bn sales in 2023, eyes EGP 6.5n revenues in 2024

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) surpassed the set targets with total sales exceeding EGP 5 billion in 2023, according to a press release. Initial estimates indicate export revenues of around $54 million, …

Financial Results

15 November 2023 04:00 PM EIPICO logs EGP 644m consolidated net profits in 9M-23

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) recorded a surge in consolidated net profits after tax to EGP 644.14 million during the first nine months (9M) of 2023. The generated net profits were compared with EGP …

Financial Results

16 August 2023 03:21 PM EIPICO’s consolidated profits hike in H1-23; sales exceed EGP 2bn

Cairo – Mubasher: The consolidated net profits after tax of Egyptian International Pharmaceutical Industries (EIPICO) hit EGP 509.28 million in the first half (H1) of 2023, versus EGP 304.38 million in H1-22, including non-controlling equity. The …

Financial Results

13 June 2023 00:42 PM EIPICO denies receiving acquisition offer

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) announced that did not receive any offers yet, according to a bourse disclosure. EIPICO’s statement came in line with news reporting that there is an anticipated …

Companies Investments

28 May 2023 10:52 AM EIPICO records higher consolidated profits in Q1-23

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) registered EGP 188.41 million in consolidated net profit after tax during the first quarter (Q1) of 2023. The generated profits were higher than EGP 173.68 million in …

Financial Results

3 April 2023 02:53 PM EIPICO’s shareholders approve 2022 dividends, capital increase

Cairo – Mubasher: The shareholders of Egyptian International Pharmaceutical Industries (EIPICO) greenlighted a cash dividend of EGP 2 per share over two equal instalments for 2022, according to a bourse filing. The ordinary general meeting (OGM) …

General Assembly

1 March 2023 05:28 PM EIPICO’s consolidated net profits near EGP 644m in 2022

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) posted consolidated net profits after tax worth EGP 643.76 million in 2022, an annual hike from EGP 488.28 million, including non-controlling equity. The sales jumped to …

Financial Results

19 February 2023 04:06 PM EIPICO’s board approves issued capital hike to EGP 1.48bn

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) obtained the board’s approval to increase its issued capital by 50% to EGP 1.48 billion from EGP 991.70 million. Meanwhile, the EGP 495.85 million raise value will be …

Companies Investments

2 January 2023 10:50 AM EIPICO’s board nods to 15% issued capital raise

Cairo – Mubasher: The board of directors of the Egyptian International Pharmaceutical Industries (EIPICO) approved increasing the company’s issued capital by 15% to EGP 1.14 billion from EGP 991.70 million. The EGP 148.75 million capital hike will …

Board of Directors

14 November 2022 04:17 PM EIPICO posts 29% growth in 9M-22 profits

Cairo – Mubasher: The consolidated financial statements of the Egyptian International Pharmaceutical Industries (EIPICO) revealed a year-on-year (YoY) surge of 28.80% in net profits during the first nine months (9M) of 2022. The company’s profits …

Financial Results

20 September 2022 10:49 AM Elsewedy Electric’s unit inks EGP 418m contract with EIPICO

Cairo – Mubasher: Rowad Modern Engineering, a subsidiary of Elsewedy Electric Co, has signed a new contract worth EGP 418 million with the Egyptian International Pharmaceutical Industries (EIPICO) for the construction of EIPICO Factory 3. Situated …

Companies Investments

10 August 2022 11:49 AM EIPICO records EGP 304.4m net earnings in H1-22

Cairo – Mubasher: The consolidated financial statements of the Egyptian International Pharmaceutical Industries (EIPICO) showed a 28.8% increase in net profits during the first half (H1) of 2022. EIPICO’s earnings netted EGP 304.38 million during …

Financial Results

26 May 2022 03:40 PM EIPICO eyes entire stake in UP Pharma

Cairo – Mubasher: Egyptian International Pharmaceutical Industries (EIPICO) is planning to fully own Upper Egypt Pharmaceuticals (UP Pharma), after the former’s board approved to proceed with the initial equity acquisition during 24 May meeting. …

Board of Directors

25 May 2022 01:50 PM EIPICO posts 21% higher profits in Q1-22

Cairo – Mubasher: The consolidated net profits of the Egyptian International Pharmaceutical Industries (EIPICO) jumped by 20.90% year-on-year (YoY) to EGP 173.68 million in the first quarter (Q1) of 2022 from EGP 143.54 million. The company …

Financial Results

23 February 2022 00:11 PM EIPICO sees 7% higher profits in 2021

Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) reported a 7.3% year-on-year (YoY) increase in its consolidated net profits to EGP 522.8 million in 2021, compared to EGP 487.4 million, including minority …

Financial Results

7 November 2021 10:57 AM EIPICO logs EGP 359m profit in nine months

Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) reported consolidated net profits of EGP 358.69 million in the first nine months of 2021, up by 5.6% year-on-year (YoY) from EGP 339.46 million, including minority …

Financial Results

27 October 2021 11:49 AM Swedish firm wins contract to build EIPICO Plant 3 with $43.5m

Cairo – Mubasher: The board of directors of the Egyptian International Pharmaceutical Industries (EIPICO) approved to assign the construction of the EIPICO 3 plant building structure to the Swedish company Pharmadule Morimatsu for a total amount …

Companies Investments

11 August 2021 00:14 PM EIPICO's profit edges up in H1-21

Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) logged consolidated net profits of EGP 270.76 million in the first half (H1) of 2021, slightly up from EGP 262.2 million in H1-20.  The pharmaceutical company's sales …

Financial Results

8 August 2021 00:35 PM EIPICO's sales exceed EGP 1.5bn in H1-21

Cairo - Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO), the largest subsidiary of Arab Company for Drug Industries and Medical Appliances (ACDIMA), achieved positive business results during the first half (H1) of …

Financial Results

10 May 2021 02:19 PM EIPICO's profit falls 6% in Q1-21

Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) achieved net profits of EGP 178.06 million in the first quarter (Q1) of 2021, down by 5.8% year-on-year (YoY) from EGP 189.1 million, according to the unaudited …

Financial Results

22 April 2021 10:47 AM EIPICO, Kambal to build $30m pharmaceutical plant in Sudan

Cairo – Mubasher: The Egyptian International Pharmaceutical Industries (EIPICO) signed a partnership agreement with Kambal International Co. to build a pharmaceutical plant in Sudan with investments of $30 million.   The two companies paid $9 …

Companies Investments